The Children's Movement of Florida’s Post

New article out in Law360 discussing the NASEM Health and Medicine Division report, Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks. The article interviews the committee chair, Mimi Foster Riley, and several law professionals summarizing that "the real legal risks stem from the failure to include [pregnant and lactating] populations in initial research." Law360 Article: https://lnkd.in/eBd3rrkJ NASEM Report: https://lnkd.in/ePZ-zJUF

There is relatively little evidence assessing outcomes of onabotulinomtoxin-A injection as thirdline therapy in older adults. This study evaluates the outcomes of intradetrusor BTX-A injection in patients over 70 years old. Read more in Continence: https://lnkd.in/ebd--biB #UrinaryIncontinence #OveractiveBladder #OnabotulinumtoxinA

Urine drug screening Black mothers cannot be separated from the their heightened risk of surveillance and family separation by the family regulation system. It should not be done without full informed consent explaining all the risks involved. Clinical activism involves critically assessing basic health procedures, like urine drug screens, and seeing how they intersect with structural racism, to deepen inequities and cause harm. It takes us from doing nothing in the face of injustice and carcerality to boldly doing something to uphold our oath. 📺 Watch my full presentation here: https://lnkd.in/dp9zrk5h Let’s move from silence to action. #HealthcareEquity #DrugScreening #ChildWelfare #RacialBias #InformedConsent #HealthOutcomes #DorothyRoberts #SocialJustice #FamilyRegulation #ImplicitBias

It is crucial to understand if the benefits of treating a breastfeeding mother’s medical condition outweigh the potential risk of drug exposure to their breastfed infant. Check out this white paper to learn why lactation studies are so critical.

Support the Stop CMV Act! Congenital Cytomegalovirus (cCMV) affects approximately 1 per every 200 births in the United States. It is the most common viral cause of birth defects and is the most common cause of non-hereditary hearing loss. The bipartisan, bicameral STOP CMV Act (S. 3864/H.R.7542) authorizes new funding to incentivize hospitals and other health care entities that care for children to screen babies for CMV within the first 21 days after birth. The bill also authorizes funding to collect data on CMV and to assist in the education and training of health care providers, patients, and the public. Finally, the legislation directs the National Institutes of Health (NIH) to conduct research into congenital CMV. https://buff.ly/3Tj2MRJ

Curious about lip and tongue-tie releases? These common conditions can affect your child’s eating, speech, and oral health. Learn more in our latest blog from Dr. Marielena Torres-Ricart at Kids World Pediatric. https://bit.ly/3By2ctY

A new trial of technology which could help those with Type 1 diabetes (especially those who are pregnant) at the Norfolk and Norwich University Hospital. The experiences have been shared nationally. Find out more at https://lnkd.in/eSigQW6Z

Hospitals across the United States are routinely using inaccurate drug tests on pregnant patients, leading to false positive results and the wrongful separation of families. This harmful practice is causing immense trauma and disrupting the lives of innocent parents and children. Common medications, foods, and even over-the-counter remedies can trigger false positives, yet hospitals often fail to inform patients of this risk or use more accurate testing methods. It's time for hospitals to adopt more reliable testing procedures and prioritize the well-being of families. We must work together to protect the rights of parents and ensure that they are not wrongfully separated from their children. 📖Read "False Positive Drug Test Results Lead to Parents Being Wrongfully Reported." Learn more about this important issue and how you can help.🔗https://lnkd.in/esCkabnE #healthcare #drugtesting #familyseparation #reproductivejustice #maternalhealth

CGM use has a proven impact on the quality of life in a person with diabetes. What could that mean for pregnant patients? Research on CGM use in gestational diabetes care is limited, but there is impressive potential. In our new blog post, we're explaining how CGMs can be a valuable tool for women with gestational diabetes: https://lnkd.in/gmQwqFeb

Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more from Dr. Sue; https://buff.ly/4aRWgsn